Universal neonatal screening for sickle cell disease and other haemoglobinopathies in Ferrara, Italy.

Abstract

Currently prevention of haemoglobinopathies in Italy is provided during the pre-conception period but only to patients with abnormal blood counts. Neonatal screening is useful and cost-effective to ensure early diagnosis and appropriate treatment for infants with sickle cell disease or other haemoglobinopathies.